Lineage-affiliated transcription factors bind the Gata3 Tce1 enhancer to mediate lineage-specific programs

Journal of Clinical Investigation

Volumn 126, Issue 3, 2016, Pages 865-878

  Ohmura, Sakie ^a   Mizuno, Seiya ^b   Oishi, Hisashi ^b   Ku, Chia Jui ^a   Hermann, Mary ^a   Hosoya, Tomonori ^a   Takahashi, Satoru ^b   Engel, James Douglas ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b University of Tsukuba School of Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR HEB; UNCLASSIFIED DRUG; GATA3 PROTEIN, MOUSE; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINEAGE; CELL SPECIFICITY; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED STUDY; DEVELOPMENTAL STAGE; ENHANCER REGION; FEMALE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; STRUCTURAL GENE; T LYMPHOCYTE; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PHYSIOLOGY; THYMOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; ENHANCER ELEMENTS, GENETIC; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, TRANSGENIC; PROTEIN BINDING; THYMOCYTES; TRANSCRIPTION, GENETIC;

EID: 84959915979     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI83894     Document Type: Article

References (102)

1. Singer A, Adoro S, Park JH. Lineage fate and intense debate: myths, models and mechanisms of CD4-versus CD8-lineage choice. Nat Rev Immunol. 2008;8(10):788-801.
2. Hosoya T, Maillard I, Engel JD. From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation. Immunol Rev. 2010;238(1):110-125.
3. Yamamoto M, Ko LJ, Leonard MW, Beug H, Orkin SH, Engel JD. Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes Dev. 1990;4(10):1650-1662.
4. Ko LJ, Yamamoto M, Leonard MW, George KM, Ting P, Engel JD. Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. Mol Cell Biol. 1991;11(5):2778-2784.
5. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997;89(4):587-596.
6. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem. 1997;272(34):21597-21603.
7. Hendriks RW, Nawijn MC, Engel JD, van Doorninck H, Grosveld F, Karis A. Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur J Immunol. 1999;29(6):1912-1918.
8. Hernández-Hoyos G, Anderson MK, Wang C, Rothenberg EV, Alberola-Ila J. GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation. Immunity. 2003;19(1):83-94.
9. Sambandam A, et al. Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol. 2005;6(7):663-670.
10. David-Fung E-S, et al. Progression of regulatory gene expression states in fetal and adult pro-T-cell development. Immunol Rev. 2006;209:212-236.
11. Tydell CC, David-Fung ES, Moore JE, Rowen L, Taghon T, Rothenberg EV. Molecular dissection of prethymic progenitor entry into the T lymphocyte developmental pathway. J Immunol. 2007;179(1):421-438.
12. Hosoya T, et al. GATA-3 is required for early T lineage progenitor development. J Exp Med. 2009;206(13):2987-3000.
13. Garcia-Ojeda ME, et al. GATA-3 promotes T-cell specification by repressing B-cell potential in pro-T cells in mice. Blood. 2013;121(10):1749-1759.
14. Pai S-Y, Truitt ML, Ting C-N, Leiden JM, Glimcher LH, Ho I-C. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity. 2003;19(6):863-875.
15. Wang L, et al. Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4(+) T cells. Nat Immunol. 2008;9(10):1122-1130.
16. Pai S-Y, Truitt ML, Ho I-C. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc Natl Acad Sci U S A. 2004;101(7):1993-1998.
17. Zhu J, et al. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol. 2004;5(11):1157-1165.
18. Tai TS, Pai SY, Ho IC. GATA-3 regulates the homeostasis and activation of CD8+ T cells. J Immunol. 2013;190(1):428-437.
19. Wang T, et al. GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood. 2014;123(19):3007-3015.
20. Hoyler T, et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity. 2012;37(4):634-648.
21. Mjosberg J, et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity. 2012;37(4):649-659.
22. Yagi R, et al. The transcription factor GATA3 is critical for the development of all IL-7R-expressing innate lymphoid cells. Immunity. 2014;40(3):378-388.
23. Samson SI, et al. GATA-3 promotes maturation, IFN-production, and liver-specific homing of NK cells. Immunity. 2003;19(5):701-711.
24. Vosshenrich CA, et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat Immunol. 2006;7(11):1217-1224.
25. Banerjee A, Northrup D, Boukarabila H, Jacobsen SE, Allman D. Transcriptional repression of Gata3 is essential for early B cell commitment. Immunity. 2013;38(5):930-942.
26. Chen D, Zhang G. Enforced expression of the GATA-3 transcription factor affects cell fate decisions in hematopoiesis. Exp Hematol. 2001;29(8):971-980.
27. Nawijn MC, et al. Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice. J Immunol. 2001;167(2):715-723.
28. Taghon T, De Smedt M, Stolz F, Cnockaert M, Plum J, Leclercq G. Enforced expression of GATA-3 severely reduces human thymic cellularity. J Immunol. 2001;167(8):4468-4475.
29. Anderson MK, Hernandez-Hoyos G, Dionne CJ, Arias AM, Chen D, Rothenberg EV. Definition of regulatory network elements for T cell development by perturbation analysis with PU. Dev Biol. 2002;246(1):103-121.
30. Taghon T, Yui MA, Rothenberg EV. Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3. Nat Immunol. 2007;8(8):845-855.
31. Ano S, et al. Transcription factors GATA-3 and RORt are important for determining the phenotype of allergic airway inflammation in a murine model of asthma. J Immunol. 2013;190(3):1056-1065.
32. KleinJan A, et al. Enforced expression of Gata3 in T cells and group 2 innate lymphoid cells increases susceptibility to allergic airway inflammation in mice. J Immunol. 2014;192(4):1385-1394.
33. Atayar C, Poppema S, Blokzijl T, Harms G, Boot M, van den Berg A. Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas. Am J Pathol. 2005;166(1):127-134.
34. Stanelle J, Doring C, Hansmann ML, Kuppers R. Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells. Blood. 2010;116(20):4202-4211.
35. Van Esch H, et al. GATA3 haplo-insufficiency causes human HDR syndrome. Nature. 2000;406(6794):419-422.
36. Hosoya-Ohmura S, et al. An NK and T cell enhancer lies 280 kilobase pairs 3 to the gata3 structural gene. Mol Cell Biol. 2011; 31(9):1894-1904.
37. Braunstein M, Anderson MK. HEB-deficient T-cell precursors lose T-cell potential and adopt an alternative pathway of differentiation. Mol Cell Biol. 2011;31(5):971-982.
38. Jones-Mason ME, Zhao X, Kappes D, Lasorella A, Iavarone A, Zhuang Y. E protein transcription factors are required for the development of CD4(+) lineage T cells. Immunity. 2012;36(3):348-361.
39. Weber BN, et al. A critical role for TCF-1 in T-lineage specification and differentiation. Nature. 2011;476(7358):63-68.
40. Amsen D, et al. Direct regulation of gata3 expression determines the T helper differentiation potential of Notch. Immunity. 2007;27(1):89-99.
41. Notani D, et al. Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner. PLoS Biol. 2010;8(1):e1000296.
42. Yang H, Wang H, Shivalila CS, Cheng AW, Shi L, Jaenisch R. One-step generation of mice carrying reporter and conditional alleles by CRISPR/ Cas-mediated genome engineering. Cell. 2013;154(6):1370-1379.
43. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science. 1995;269(5229):1427-1429.
44. Fujii W, Kawasaki K, Sugiura K, Naito K. Efficient generation of large-scale genome-modified mice using gRNA and CAS9 endonuclease. Nucleic Acids Res. 2013;41(20):e187.
45. Gerberick GF, Cruse LW, Miller CM, Sikorski EE, Ridder GM. Selective modulation of T cell memory markers CD62L and CD44 on murine draining lymph node cells following allergen and irritant treatment. Toxicol Appl Pharmacol. 1997;146(1):1-10.
46. George KM, et al. Embryonic expression and cloning of the murine GATA-3 gene. Development. 1994;120(9):2673-2686.
47. Grosveld F, van Assendelft GB, Greaves DR, Kollias G. Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell. 1987;51(6):975-985.
48. Whyte WA, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153(2):307-319.
49. Steinke FC, et al. TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4(+) T cell fate and interact with Runx3 to silence Cd4 in CD8(+) T cells. Nat Immunol. 2014;15(7):646-656.
50. Fang TC, Yashiro-Ohtani Y, Del Bianco C, Knoblock DM, Blacklow SC, Pear WS. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity. 2007;27(1):100-110.
51. Maillard I, et al. The requirement for Notch signaling at the beta-selection checkpoint in vivo is absolute and independent of the pre-T cell receptor. J Exp Med. 2006;203(10):2239-2245.
52. Maillard I, Fang T, Pear WS. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev Immunol. 2005;23:945-974.
53. van de Wetering M, Oosterwegel M, Dooijes D, Clevers H. Identification and cloning of TCG-1, a T lymphocyte-specific transcription factor con-taining a sequence-specific HMG box. EMBO J. 1991;10(1):123-132.
54. Germar K, et al. T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proc Natl Acad Sci U S A. 2011;108(50):20060-20065.
55. Verbeek S, et al. An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature. 1995;374(6517):70-74.
56. Yu Y, et al. Bcl11a is essential for lymphoid development and negatively regulates p53. J Exp Med. 2012;209(13):2467-2483.
57. Setoguchi R, et al. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science. 2008;319(5864):822-825.
58. Li L, et al. A far downstream enhancer for murine Bcl11b controls its T-cell specific expression. Blood. 2013;122(6):902-911.
59. Hu JS, Olson EN, Kingston RE. HEB, a helixloop-helix protein related to E2A and ITF2 that can modulate the DNA-binDing ability of myogenic regulatory factors. Mol Cell Biol. 1992;12(3):1031-1042.
60. Barndt R, Dai MF, Zhuang Y. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during thymopoiesis. J Immunol. 1999;163(6):3331-3343.
61. Wojciechowski J, Lai A, Kondo M, Zhuang Y. E2A and HEB are required to block thymocyte proliferation prior to pre-TCR expression. J Immunol. 2007;178(9):5717-5726.
62. Jones ME, Zhuang Y. Acquisition of a functional T cell receptor during T lymphocyte development is enforced by HEB and E2A transcription factors. Immunity. 2007;27(6):860-870.
63. Kawai Y, et al. Claudin-4 induction by E-protein activity in later stages of CD4/8 doublepositive thymocytes to increase positive selection efficiency. Proc Natl Acad Sci U S A. 2011;108(10):4075-4080.
64. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binDing proteins. Cell. 1990;61(1):49-59.
65. Kee BL. E and ID proteins branch out. Nat Rev Immunol. 2009;9(3):175-184.
66. Rivera RR, Johns CP, Quan J, Johnson RS, Murre C. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity. 2000;12(1):17-26.
67. Radtke F, et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity. 1999;10(5):547-558.
68. Wolfer A, et al. Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. Nat Immunol. 2001;2(3):235-241.
69. Wu L, Aster JC, Blacklow SC, Lake R, Artavanis-Tsakonas S, Griffin JD. MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet. 2000;26(4):484-489.
70. Hsieh JJ, Henkel T, Salmon P, Robey E, Peterson MG, Hayward SD. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol Cell Biol. 1996;16(3):952-959.
71. Höflinger S, et al. Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors. J Immunol. 2004;173(6):3935-3944.
72. Rothenberg EV, Taghon T. Molecular genetics of T cell development. Annu Rev Immunol. 2005;23:601-649.
73. Guo Y, Maillard I, Chakraborti S, Rothenberg EV, Speck NA. Core binDing factors are necessary for natural killer cell development, and cooperate with Notch signaling during T cell specification. Blood. 2008;112(3):480-492.
74. Ku CJ, Hosoya T, Maillard I, Engel JD. GATA-3 regulates hematopoietic stem cell maintenance and cell-cycle entry. Blood. 2012;119(10):2242-2251.
75. Maurice D, Hooper J, Lang G, Weston K. c-Myb regulates lineage choice in developing thymocytes via its target gene Gata3. EMBO J. 2007;26(15):3629-3640.
76. Yang XO, et al. Requirement for the basic helix-loop-helix transcription factor Dec2 in initial TH2 lineage commitment. Nat Immunol. 2009;10(12):1260-1266.
77. Yui MA, Rothenberg EV. Developmental gene networks: a triathlon on the course to T cell identity. Nat Rev Immunol. 2014;14(8):529-545.
78. Giese K, Cox J, Grosschedl R. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell. 1992;69(1):185-195.
79. Bebin AG, et al. In vivo redundant function of the 3 IgH regulatory element HS3b in the mouse. J Immunol. 2010;184(7):3710-3717.
80. Cretekos CJ, Wang Y, Green ED, Martin JF, Behringer RR. Regulatory divergence modifies limb length between mammals. Genes Dev. 2008;22(2):141-151.
81. Xiong N, Kang C, Raulet DH. Redundant and unique roles of two enhancer elements in the TCRgamma locus in gene regulation and gammadelta T cell development. Immunity. 2002;16(3):453-463.
82. Hong JW, Hendrix DA, Levine MS. Shadow enhancers as a source of evolutionary novelty. Science. 2008;321(5894):1314.
83. Chen JC, Ramachandran R, Goldhamer DJ. Essential and redundant functions of the MyoD distal regulatory region revealed by targeted mutagenesis. Dev Biol. 2002;245(1):213-223.
84. Barolo S. Shadow enhancers: frequently asked questions about distributed cis-regulatory information and enhancer redundancy. Bioessays. 2012;34(2):135-141.
85. Gruver AL, Sempowski GD. Cytokines, leptin, and stress-induced thymic atrophy. J Leukoc Biol. 2008;84(4):915-923.
86. Perry MW, Boettiger AN, Levine M. Multiple enhancers ensure precision of gap gene-expression patterns in the Drosophila embryo. Proc Natl Acad Sci U S A. 2011;108(33):13570-13575.
87. Montavon T, et al. A regulatory archipelago controls Hox genes transcription in digits. Cell. 2011;147(5):1132-1145.
88. Hasegawa SL, Moriguchi T, Rao A, Kuroha T, Engel JD, Lim K-C. Dosage-dependent rescue of definitive nephrogenesis by a distant Gata3 enhancer. Dev Biol. 2007;301(2):568-577.
89. Lakshmanan G, Lieuw KH, Grosveld F, Engel JD. Partial rescue of GATA-3 by yeast artificial chromosome transgenes. Dev Biol. 1998;204(2):451-463.
90. Lakshmanan G, et al. Localization of distant urogenital system-, central nervous system-, and endocardium-specific transcriptional regulatory elements in the GATA-3 locus. Mol Cell Biol. 1999;19(2):1558-1568.
91. Lieuw KH, Li G, Zhou Y, Grosveld F, Engel JD. Temporal and spatial control of murine GATA-3 transcription by promoter-proximal regulatory elements. Dev Biol. 1997;188(1):1-16.
92. De S, Wurster AL, Precht P, Wood WH 3rd, Becker KG, Pazin MJ. Dynamic BRG1 recruitment during T helper differentiation and activation reveals distal regulatory elements. Mol Cell Biol. 2011;31(7):1512-1527.
93. Perez-Andreu V, et al. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet. 2013;45(12):1494-1498.
94. Perez-Andreu V, et al. A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. Blood. 2015;125(4):680-686.
95. Migliorini G, et al. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype. Blood. 2013;122(19):3298-3307.
96. Enciso-Mora V, et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16. Nat Genet. 2010;42(12):1126-1130.
97. Huebner M, Kim DY, Ewart S, Karmaus W, Sadeghnejad A, Arshad SH. Patterns of GATA3 and IL13 gene polymorphisms associated with childhood rhinitis and atopy in a birth cohort. J Allergy Clin Immunol. 2008;121(2):408-414.
98. Pykalainen M, et al. Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes. J Allergy Clin Immunol. 2005;115(1):80-87.
99. Hirota T, et al. Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet. 2011;43(9):893-896.
100. Cong L, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013; 339(6121):819-823.
101. Loots GG, Ovcharenko I. rVISTA 2.0: evolutionary analysis of transcription factor binDing sites. Nucleic Acids Res. 2004; 32(Web Server issue):W217-W221.
102. Loots GG, Ovcharenko I, Pachter L, Dubchak I, Rubin EM. rVista for comparative sequencebased discovery of functional transcription factor binDing sites. Genome Res. 2002;12(5):832-839.